2012
DOI: 10.2174/156720112801323053
|View full text |Cite
|
Sign up to set email alerts
|

Polymers and Drug Delivery Systems

Abstract: In the treatment of health related dysfunctions, it is desirable that the drug reaches its site of action at a particular concentration and that this therapeutic dose range remains constant over a sufficiently long period of time to alter the process. However, the action of pharmaceutical agents is limited by various factors, including their degradation, their interaction with other cells, and their incapacity to penetrate tissues as a result of their chemical nature. For these reasons, new formulations are be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
164
0
8

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 244 publications
(172 citation statements)
references
References 97 publications
0
164
0
8
Order By: Relevance
“…(2) where N is normality of hydrogen bromide (HBr), while v is volume of HBr in mL and w is weight of resin in gram.…”
Section: Characterization Of the Precursor's Physicochemical Propertimentioning
confidence: 99%
See 1 more Smart Citation
“…(2) where N is normality of hydrogen bromide (HBr), while v is volume of HBr in mL and w is weight of resin in gram.…”
Section: Characterization Of the Precursor's Physicochemical Propertimentioning
confidence: 99%
“…Polymers are amongst the most extensively explored and widely use materials as drug vehicles for localized and sustained delivery of drug (medication) to a patient [1,2]. There are different types of drug vehicles such as macromolecular carriers (macromolecular prodrugs, protein-macromolecule conjugates and gene medicines complexed with macromolecular carriers), particulate carriers (micro/nanoparticles, liposomes, dendrimers, lipoproteins, nanotubes, micro/nanospheres and micro/nanoemulsions) and cellular carriers (leucocytes, platelets, erythrocytes, nanoerythrocytes, hepatocytes, and fibroblast) [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…However, a burst release of drug was found prevalent in these polymeric matrixes leading to potentially serious consequences for the patients. The improved polymeric matrixes were developed, but feedback-controlled release and other problems with many polymeric DDS limited their practical application (Kumari et al, 2010;Mora-Huertas et al, 2010;Vilar et al, 2012;Sood et al, 2014).…”
Section: Rationale For Mips Application In Ddsmentioning
confidence: 99%
“…They can be used in drug-delivery systems [1], for artificial body implants (vascular grafts, stents and heart valves), as scaffolds for ligament and tendon repair, for urinary and vascular catheters, dialysis membranes, orthopedic implants, etc. [2].…”
Section: Introductionmentioning
confidence: 99%